Baseline participant demographics
| Intervention (n=60) | Control (n=60) | |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 64.4 (11.3) | 62.6 (13.4) |
| Median (IQR) | 66.0 (16.5) | 62.5 (20.5) |
| Sex (females) | 31 (51.7%) | 35 (58.3%) |
| Education level | ||
| Primary | 13 (21.7%) | 9 (15.0%) |
| Secondary | 32 (53.3%) | 37 (61.7%) |
| Tertiary | 15 (25.0%) | 14 (23.3%) |
| Total number of medicines | ||
| Medications | ||
| Mean (SD) | 5.7 (2.6) | 5.0 (2.6) |
| Median (IQR) | 5.0 (3.0) | 5.0 (4.0) |
| Range | 1–12 | 1–14 |
| Complementary medicines | ||
| Mean (SD) | 0.85 (1.1) | 0.93 (1.3) |
| Median (IQR) | 0.5 (1.0) | 1.0 (1.0) |
| Range | 0–4 | 0–6 |
| Total number of medical conditions | ||
| Mean (SD) | 3.6 (1.3) | 3.5 (1.6) |
| Median (IQR) | 3.0 (2.0) | 4.0 (2.0) |
| Range | 1–7 | 1–8 |
| Medical conditions | ||
| Hypertension | 49 (81.7%) | 48 (80.0%) |
| Dyslipidaemia | 39 (65.0%) | 39 (65.0%) |
| Diabetes mellitus | 24 (40.0%) | 25 (41.7%) |
| Heart failure | 8 (13.3%) | 5 (8.3%) |
| Atrial fibrillation | 7 (11.7%) | 4 (6.7%) |
| Myocardial infarction | 5 (8.3%) | 10 (16.7%) |
| Stroke | 4 (6.7%) | 5 (8.3%) |
| Depression | 12 (20.0%) | 12 (20.0%) |
| Osteoarthritis | 19 (31.7%) | 17 (28.3%) |
| Gout | 2 (3.3%) | 5 (8.3%) |
| Osteoporosis | 6 (10.0%) | 3 (5.0%) |
| Asthma | 9 (15.0%) | 9 (15.0%) |
| Chronic obstructive pulmonary disease | 2 (3.3%) | 1 (1.7%) |
| Gastro-oesophageal reflux disorder | 10 (16.7%) | 5 (8.3%) |
| Thyroid conditions | 3 (5.0%) | 3 (5.0%) |
| Other | 17 (28.3%) | 20 (33.3%) |
Data: number (%) or mean (SD).